Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsChild and adolescent psychiatry — neurodevelopmental

Psych MEQs / SAQs · Child and adolescent psychiatry — neurodevelopmental

Autism spectrum disorder — assessment to irritability management (MEQ)

FRANZCP-style MEQ on ASD criteria, differentials, early intervention evidence, irritability pharmacotherapy with monitoring, and transition/capacity framing.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 7-year-old boy with longstanding social-communication difficulties, intense interest in train timetables, and distress at minor routine changes is brought after 3 months of daily aggression and self-hitting causing bruising. School describes meltdowns when plans change. Hearing was normal at age 3; no seizures. He meets clinical criteria for ASD. (i) State the DSM-5-TR structure required for ASD and how severity is rated. (ii) Outline key differentials from ADHD, intellectual disability, social anxiety and social (pragmatic) communication disorder with discriminators. (iii) Describe the non-pharmacological package and name at least two landmark intervention trials. (iv) Indicate when risperidone or aripiprazole would be considered, with a named starting approach, monitoring and an evidence landmark for each class of agent. (v) List capacity/transition issues you would anticipate for later adolescence. (20 marks)

Model answer

Reveal model answer

(i) Criteria and severity. ASD requires persistent deficits in all three social-communication domains (reciprocity; nonverbal communicative behaviour; relationships) and at least two of four RRB domains (stereotypies/repetitive speech or object use; insistence on sameness; restricted interests; sensory hyper/hyporeactivity), early developmental onset, impairment, and not better explained by intellectual disability alone. Rate severity separately for social communication and RRBs as Level 1–3 support need.[1]

(ii) Differentials. ADHD: inattention/impulsivity core; social interest often present; high co-occurrence. ID alone: social skills roughly match developmental level; ASD requires deficit beyond developmental expectation. Social anxiety: fear of scrutiny with skills often intact when comfortable. SCD: social language deficits without RRBs. This child has RRBs (timetables, sameness distress) → ASD not SCD.[1]

(iii) Non-drug package. Educational adjustments, speech/OT, structured behavioural supports, parent training, and early developmental intervention. Name ESDM (Dawson RCT) and PACT (Green parent-mediated RCT); Bearss parent training for disruptive behaviour outperforms education alone.[4][5][6]

(iv) Irritability medicines. After functional analysis, medical pain screen and behavioural optimisation, severe ongoing aggression/self-injury may justify risperidone (RUPP/McCracken: low weight-based start e.g. about 0.25–0.5 mg/day with slow titration; monitor weight, metabolic panel, EPS, prolactin) or aripiprazole (Owen: start commonly 2 mg daily, titrate toward trial effective range; monitor metabolic effects and akathisia). Neither treats core social deficits. Review for dose minimisation once stable.[2][3]

(v) Capacity and transition. Decision-specific capacity with supported decision-making; least restrictive care under local law. From mid-teens plan CAMHS-to-adult transition: written care plan, education/employment, medication review, housing, safeguarding against exploitation, and adult mental health follow-up for comorbidity risk.[1]

Common errors

  • Saying any peer problem equals ASD.
  • Prescribing antipsychotics for mild meltdowns without behavioural formulation.
  • Claiming SSRIs treat core RRBs (citalopram negative trial knowledge helps avoid this).
  • Inventing foreign Mental Health Act section numbers.
  • Omitting metabolic monitoring for risperidone/aripiprazole. [2][3]

Examiner notes

Full marks need DSM structure with levels, at least three discriminators, named early intervention trials, named drug with start approach and monitoring, and transition/capacity principles. Vague "refer to paeds and start an atypical" fails. [1][2]

References

  1. [1]Hyman SL, Levy SE, Myers SM; Council on Children with Disabilities, Section on Developmental and Behavioral Pediatrics Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Pediatrics, 2020.PMID 31843864
  2. [2]McCracken JT, McGough J, Shah B, et al.; Research Units on Pediatric Psychopharmacology Autism Network Risperidone in children with autism and serious behavioral problems N Engl J Med, 2002.PMID 12151468
  3. [3]Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder Pediatrics, 2009.PMID 19948625
  4. [4]Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model Pediatrics, 2010.PMID 19948568
  5. [5]Green J, Charman T, McConachie H, et al. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial Lancet, 2010.PMID 20494434
  6. [6]Bearss K, Johnson C, Smith T, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial JAMA, 2015.PMID 25898050